Viatris Inc vs Wipro Limited — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while Wipro Limited trades at $1.83 (market cap $18.49B). The key difference: Viatris Inc and Wipro Limited are close in size by market cap, and Wipro Limited pays the higher dividend (4.68%). Which is the better fit depends on your goals.
| VTRS | WIT | |
|---|---|---|
Market Cap | $19.79B | $18.49B |
Sector | Health | Technology |
52-Week High | $17.39 | $3.06 |
52-Week Low | $8.74 | $1.82 |
Enterprise Value | $32.00B | $16.42B |
Dividend Yield | 2.83% | 4.68% |
Trailing returns across standard periods
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →